These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5761261)

  • 1. [Ocular changes experimentally induced in guinea pigs treated with an association of kallikrein and meso-inositol hexanicotinate].
    Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):544-54. PubMed ID: 5761261
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the fibrinolytic effect of the combination of kallikrein with meso-inositol hexanicotinate].
    Zedda S
    Clin Ter; 1967 Sep; 42(6):509-24. PubMed ID: 5617888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].
    Paltauf F; Pristautz H; el Eisch IA
    Acta Med Austriaca; 1977; 4(3):120-4. PubMed ID: 930544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PHARMACOLOGICAL EXPERIMENTS WITH A COMBINATION OF KALLIKREIN AND MESO-INOSITOL HEXANICOTINATE].
    PAGLIANI P; GIOSEFFI G
    Boll Chim Farm; 1964 Jul; 103():504-21. PubMed ID: 14200698
    [No Abstract]   [Full Text] [Related]  

  • 7. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ocular and lacrimal apparatus lesions in guinea pigs experimentally treated with exhaust gas from automobiles with gasoline engines].
    Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):697-716. PubMed ID: 4099663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical review on vasodilators].
    Goto F; Akiyama M
    Jibiinkoka; 1969 Oct; 40(10):785-96. PubMed ID: 4236877
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of meso-inositol hexanicotinate on arteriosclerosis].
    Kimura N; Nishimoto S; Mori I; Mizuguchi N; Yoshinaga M
    Nihon Rinsho; 1966 Mar; 24(3):576-82. PubMed ID: 6007313
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resorption, blood levels and elimination of meso-inositol-14C-hexanicotinate following oral administration to cats].
    Brattgård SO; Brattsand R; Harthon JG
    Arzneimittelforschung; 1966 Feb; 16(2):145-6. PubMed ID: 6014006
    [No Abstract]   [Full Text] [Related]  

  • 12. New observations on the modifications experimentally induced in the magnocellular hypothalamic nuclei of rats and guinea pigs.
    D'Amelio FE; Azcoaga JE
    Yokohama Med Bull; 1967 Oct; 18(5):153-60. PubMed ID: 6081787
    [No Abstract]   [Full Text] [Related]  

  • 13. [FIRST EXPERIENCES ON THE THERAPEUTIC ACTIVITY OF M-INOSITOL HEXANICOTINATE AND KALLIKREIN IN PERIPHERAL VASCULAR DISEASES AND IN CORONARY DISEASE].
    LIOTTA S
    Policlinico Prat; 1964 Dec; 71():1874-84. PubMed ID: 14253722
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nibufin on the electric activity of the eye and on the function and morphology of the lacrimal gland].
    Lapina IA; Sukhinin VP
    Farmakol Toksikol; 1968; 31(1):18-22. PubMed ID: 5675340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
    Sommer H
    Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental ocular changes induced in guinea pigs treated with isoproterenol. Anatomo-histopathological findings].
    Pellegrini N; Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):1085-96. PubMed ID: 6001537
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the ganglioplegic properties of hexanicit].
    Mercier J; Dessaigne S
    C R Seances Soc Biol Fil; 1966; 160(12):2401-4. PubMed ID: 4383295
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of inositol hexanicotinate in rat plasma by high performance liquid chromatography with UV detection.
    Liang D; Ma J; Wei B; Poon IO; Bell EC; Bates TR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):172-6. PubMed ID: 18207467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the hepatoprotective lipotropic proprieties of hexanicit].
    Mercier J; Lumbroso A; Vovan L; Dessaigne S
    Therapie; 1967; 22(5):1153-8. PubMed ID: 4171247
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL TESTING OF MESO-INOSITOL-HEXANICOTINATE].
    OKADA Y; HANADA M; SUGIURA Y
    No To Shinkei; 1963 Nov; 15():1081-5. PubMed ID: 14096451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.